Home » Xoma Licenses Technology to Pfizer
Xoma Licenses Technology to Pfizer
Xoma said early Tuesday that it has licensed its bacterial cell expression technology to Pfizer Inc. for use in developing antibody-based treatments.
Marketwatch
Upcoming Events
-
07May
-
14May
-
30May